高级检索
当前位置: 首页 > 详情页

China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)

文献详情

资源类型:
文献类型:
刊名:
ISSN:
年份:

摘要:
Hepatocellular carcinoma (HCC), which accounts for approximately 75-85% of primary liver cancers, ranks 4th in newly diagnosed cases among various types of cancer in China, and is the 2nd leading cause of cancer-related mortality, thereby posing a significant threat to the life and health of the Chinese population. Since the publication of the "Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China" in June 2017, which were updated by the China's National Health Commission in December 2019 and December 2021, additional high-quality evidence from researchers worldwide regarding the diagnosis, staging, and treatment of HCC has emerged, necessitating another update to the guidelines. The new edition (2024 Edition) was written by more than 120 multidisciplinary experts in the field of HCC in China, which not only reflects the real-world situation in China but also may reshape the nationwide diagnosis and treatment of HCC. The new guideline aims to encourage the implementation of evidence-based practice and improve the national average 5-year survival rate for patients with HCC, as proposed in the "Healthy China 2030: A Vision for Health Care."© 2025 The Author(s). Published by S. Karger AG, Basel.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学 2 区 肿瘤学
专家组成员:
Zhou Jian (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Sun Huichuan (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Wang Zheng (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Cong Wenming (Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Zeng Mengsu (Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.) Zhou Weiping (Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Liu Lianxin (Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.) Wen Tianfu (Department of Liver Surgery and Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.) Kuang Ming (Center of Hepato-Pancreate-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.) Zhang Bixiang (Hepatic Surgery Center, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.) Tao Kaishan (Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.) Han Guohong (Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.) Yan Zhiping (Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.) Wang Maoqiang (Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, China.) Liu Ruibao (Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin, China.) Guo Jinhe (Department of Interventional and Vascular Surgery, Zhongda Hospital, Southeast University, Nanjing, China.) Zeng Zhaochong (Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.) Liang Ping (Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China.) Ren Zhenggang (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Hou Jinlin (Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.) Zhang Yanqiao (Department of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.) Liu Xiufeng (Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China.) Pan Hongming (Department of Medical Oncology, Sir Run-Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.) Bi Feng (Department of Abdominal Tumors, West China Hospital, Sichuan University, Chengdu, China.) Liang Changhong (Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.) Chen Min (Department of Radiology, Beijing Hospital, Peking University, Beijing, China.) Yan Fuhua (Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.) Xu Huixiong (Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China.) Xie Xiaoyan (Department of Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.) Ju Shenghong (Department of Radiology, Zhongda Hospital, Southeast University, Nanjing, China.) Ji Yuan (Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.) Yun Jingping (Department of Pathology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China.) Li Zengshan (Department of Pathology, Xijing Hospital and School of Basic Medicine, Xi'an, China.) Bai Xueli (Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.) Cai Dingfang (Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.) Chen Weixia (Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.) Chen Yajin (Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.) Chen Yongjun (Department of Hematology, Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai, China.) Cheng Wenwu (Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.) Cheng Shuqun (Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Dai Zhi (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Dai Chaoliu (Department of Hepatobiliary and Spleeny Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang, China.) Gao Qiang (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Guo Rongping (Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.) Guo Wengzhi (Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.) Guo Yabing (Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.) Hua Baojin (Graduate School, Beijing University of Chinese Medicine, Beijing, China.) Huang Xiaowu (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Jiang Hanyu (Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.) Jia Weidong (Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei, China.) Li Qiu (Department of Oncology, West China Hospital, Sichuan University, Chengdu, China.) Li Tao (Department of General Surgery, Qilu Hospital, Shandong University, Jinan, China.) Li Xiangcheng (Department of Hepatobiliary Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.) Li Xun (Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.) Li Yaming (Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang, China.) Li Yexiong (Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.) Liang Jun (Department of Oncology, Peking University International Hospital, Beijing, China.) Liang Xiao (Key Laboratory of Laparoscopic Technology of Zhejiang Province, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.) Ling Changquan (Oncology Department of Traditional Chinese Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China.) Liu Hui (Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Liu Tianshu (Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.) Lu Shichun (Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing, China.) Lv Guoyue (Department of General Surgery, the First Hospital of Jilin University, Changchun, China.) Mao Yilei (Department of Hepatic Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.) Meng Zhiqiang (Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.) Peng Tao (Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.) Ren Weixin (Department of Interventional Radiology the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.) Shi Guoming (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Shi Hongcheng (Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.) Shi Ming (Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.) Song Tianqiang (Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.) Tan Guang (Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.) Wang Jianhua (Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.) Wang Kui (Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Wang Lu (Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.) Wang Wentao (Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.) Wang Xiaoying (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Wang Zhiming (Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, China.) Xiang Bangde (Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.) Xia Jun (GRADE Center, The University of Nottingham Ningbo, Ningbo, China.) Xing Baocai (Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital and Institute, Beijing, China.) Xu Jianming (Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing, China.) Xu Jun (Department of Surgery, The First Hospital of Shanxi Medical University, Taiyuan, China.) Yang Jianyong (Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.) Yang Xinrong (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Yang Yefa (Department of Hepatic Surgery and Interventional Radiology, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Yang Yunke (Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.) Yao Xiaohong (Institute of Pathology and Southwest Cancer Center, Third Military Medical University (Army Medical University), Chongqing, China.) Yin Zhenyu (Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, China.) Yuan Zhengang (Department of Oncology, the Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.) Zeng Yongyi (Department of Hepatobiliary Surgery, Affiliated Hospital of Fujian Medical University, Fuzhou, China.) Zeng Yong (Center of Hepato-Pancreate-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.) Zhang Boheng (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Zhang Leida (Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.) Zhang Shuijun (Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.) Zhang Ti (Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.) Zhang Zhiwei (Hepatic Surgery Centre at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.) Zhao Ming (Minimally Invasive Interventional Division, Liver Cancer Group, Sun Yat-Sen University Cancer Center, Guangzhou, China.) Zhao Yongfu (Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.) Zheng Honggang (Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.) Zhou Ledu (Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.) Zhu Jiye (Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.) Zhu Kangshun (Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.) Shi Yinghong (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Liu Rong (Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.) Zhang Lan (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Xiao Yongsheng (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Yang Chun (Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.) Wu Zhifeng (Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.) Ding Zhengbin (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Zhu Xiaodong (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Tang Zheng (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Huang Xiaoyong (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.) Han Hong (Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China.)
通讯作者:
Wu Hong (wuhong@scu.edu.cn) Chen Minshan (cms64@163.com) Wang Weilin (wam@zju.edu.cn) Li Qiang (402052195@qq.com) Cai Jianqiang (caijianqiang188@sina.com) Shen Feng (shenfengehbh@sina.com) Cai Xiujun (srrsh_cxj@zju.edu.cn) Qin Shukui (qinsk@csco.org.cn) Teng Gaojun (gjteng@vip.sina.com) Fan Jia (fan.jia@zs-hospital.sh.cn)
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号